PATHOLOGICAL OUTCOME OF HER2/NEU-POSITIVE EARLY BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY. FMHR. 2025;3(7):1552-1558. Accessed August 12, 2026. https://fmhr.net/index.php/fmhr/article/view/1887